Search results for "Helicobacter"

showing 10 items of 186 documents

Molecular detection of Helicobacter pylori in oral samples from patients suffering digestive pathologies

2010

Objective: to determine the simultaneous presence of H. pylori in both the oral cavity and gastric mucosal in patients suffering digestive pathologies and to establish the possible association between the presence of H. pylori in the oral cavity and the gingivoperiodontal pathology. Study design: Patients with gastric symptoms (case group) and asymptomatic patients (control group) seen at the Gastroenterology Department of Dr. Julio C. Perrando Hospital (Resistencia, Argentina) were selected. Dental plaque and saliva samples from both groups were obtained. In the case group, gastric biopsy samples were also taken. H. pylori was detected in gastric biopsies by histological stains, and Polyme…

AdultMalemedicine.medical_specialtySalivaPathologyAdolescentDigestive System DiseasesDental PlaqueDiseaseDental plaqueGastroenterologyAsymptomaticlaw.inventionYoung AdultlawInternal medicineMedicineHumansYoung adultRisk factorChildSalivaGeneral DentistryPolymerase chain reactionAgedMouthbiologyHelicobacter pyloribusiness.industryHelicobacter pyloriMiddle Agedbiology.organism_classificationmedicine.disease:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesOtorhinolaryngologyMolecular Diagnostic TechniquesGastric MucosaChild PreschoolUNESCO::CIENCIAS MÉDICASSurgeryFemalemedicine.symptombusiness
researchProduct

Sociodemographic, Lifestyle and Medical Factors Associated with Helicobacter Pylori Infection

2020

Background and Aims: The prevalence of Helicobacter pylori (H. pylori) infection is higher in developing countries and is often linked to lower socioeconomic status. Few studies have investigated the association between H. pylori and individual level characteristics in Europe, where several countries have a high prevalence of H. pylori infection. The study aimed to identify risk factors for H. pylori infection among adults in a large clinical trial in Latvia.
 Methods: 1,855 participants (40-64 years) of the “Multicenter randomized study of H. pylori eradication and pepsinogen testing for prevention of gastric cancer mortality” (GISTAR study) in Latvia tested for H. pylori IgG antibodi…

AdultMalemedicine.medical_specialtySocial Determinants of HealthBinge drinkingDiseaseRisk AssessmentBinge DrinkingHelicobacter Infectionslaw.inventionRandomized controlled trialRisk FactorslawInternal medicinemedicineHumansLife StyleSocioeconomic statusRandomized Controlled Trials as TopicUnivariate analysisHelicobacter pyloribiologybusiness.industrySmokingGastroenterologyOdds ratioMiddle AgedHelicobacter pyloribiology.organism_classificationLatviaDietClinical trialCross-Sectional StudiesSocioeconomic FactorsFemalebusinessJournal of Gastrointestinal and Liver Diseases
researchProduct

Effect of intravenous application of esomeprazole 40???mg versus pantoprazole 40???mg on 24-hour intragastric pH in healthy adults

2007

BACKGROUND: It has been demonstrated that therapy with proton pump inhibitors reduces recurrence of bleeding following initial endoscopic treatment of bleeding peptic ulcers. AIM: This study compared the effects of esomeprazole 40 mg and pantoprazole 40 mg on intragastric acid control. Both substances were administered intravenously as 15-min infusion and as bolus injection. METHODS: Healthy men and women volunteers were enrolled in this single-center, open, randomized, three-way crossover study. After administration of esomeprazole 40 mg and pantoprazole 40 mg intravenously as 15-min infusion, and pantoprazole 40 mg intravenously as bolus injection, continuous 24-h intragastric pH monitori…

AdultMalemedicine.medical_specialtymedicine.drug_classPepticProton-pump inhibitorPharmacologyGastroenterology2-PyridinylmethylsulfinylbenzimidazolesHelicobacter InfectionsEsomeprazoleGastric AcidInternal medicineHumansMedicineEsomeprazole SodiumInfusions IntravenousPantoprazoleMonitoring PhysiologicPantoprazoleCross-Over StudiesHelicobacter pyloriHepatologybusiness.industryStomachGastroenterologyEsomeprazoleGastric Acidity DeterminationHydrogen-Ion ConcentrationMiddle AgedAnti-Ulcer AgentsCrossover studymedicine.anatomical_structureInjections IntravenousBody ConstitutionGastric acidFemalebusinessmedicine.drugEuropean Journal of Gastroenterology & Hepatology
researchProduct

The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.

1996

BACKGROUND: The combination of omeprazole with amoxycillin or clarithromycin is used as treatment against Helicobacter pylori. It seems likely that the antibacterial activity of the antibiotic may be improved by increasing gastric pH towards neutrality, and a twice daily regimen of omeprazole is probably needed. AIM: To assess the effects of twice daily administration of omeprazole 20 and 40 mg. METHODS: Twelve duodenal ulcer patients in remission were randomized to receive in single-blind fashion either placebo, omeprazole 20 mg or omeprazole 40 mg twice daily (08.00 and 20.00 h). On the sixth day of dosing they underwent 24-h gastric pH-metry. RESULTS: Omeprazole 20 and 40 mg b.d. produce…

AdultMalemedicine.medical_specialtymedicine.drug_classProton-pump inhibitorGastroenterologyHelicobacter InfectionsGastric AcidInternal medicineClarithromycinmedicineHumansSingle-Blind MethodPharmacology (medical)Enzyme InhibitorsOmeprazoleGastric Acidity DeterminationCross-Over StudiesHelicobacter pyloriHepatologybiologybusiness.industryStomachGastroenterologyProton Pump InhibitorsGastric Acidity DeterminationMiddle AgedHelicobacter pyloribiology.organism_classificationCrossover studyCircadian Rhythmmedicine.anatomical_structureDuodenal UlcerDuodenumFemalebusinessOmeprazolemedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Prevalence of virulence-associated genotypes of Helicobacter pylori and correlation with severity of gastric pathology in patients from western Sicil…

2008

In a bacterium like Helicobacter pylori, which is characterized by a recombinant population structure, the associated presence of genes encoding virulence factors might be considered an expression of a selective advantage conferred to strains with certain genotypes and, therefore, a potentially useful tool for predicting the clinical outcome of infections. However, differences in the geographical and ethnic prevalence of the H. pylori virulence-associated genotypes can affect their clinical predictive value and need to be considered in advance. In this study we carried out such an evaluation in a group of patients living in Sicily, the largest and most populous island in the Mediterranean S…

AdultMicrobiology (medical)Settore MED/07 - Microbiologia E Microbiologia ClinicaVirulence FactorsBiopsySpirillaceaeChronic gastritisVirulenceHelicobacter InfectionsMicrobiologyBacterial ProteinsGenotypemedicineHumansCagAGene–environment interactionSicilyAgedHelicobacter pylori Virulence-associated genotypes Gastric pathology ItalyHelicobacter pyloribiologybusiness.industryGene Expression ProfilingGeneral MedicineMiddle AgedHelicobacter pylorimedicine.diseasebiology.organism_classificationInfectious DiseasesGastric MucosaGastritisGastritismedicine.symptombusiness
researchProduct

Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10

2014

The prevalence of allergic asthma and other atopic diseases has reached epidemic proportions in large parts of the developed world. The gradual loss of the human indigenous microbiota has been held responsible for this trend. The bacterial pathogen Helicobacter pylori is a constituent of the normal gastric microbiota whose presence has been inversely linked to allergy and asthma in humans and experimental models. Here we show that oral or i.p. tolerization with H. pylori extract prevents the airway hyperresponsiveness, bronchoalveolar eosinophilia, pulmonary inflammation, and Th2 cytokine production that are hallmarks of allergen-induced asthma in mice. Asthma protection is not conferred by…

Allergybacterial persistence determinantsT-Lymphocytes Regulatorybacterial immunomodulationImmune toleranceMiceBacterial ProteinsImmune TolerancemedicineAnimalsHumansImmunologic FactorsEosinophiliaAsthmaMice KnockoutAntigens Bacterial1000 MultidisciplinaryMultidisciplinaryHelicobacter pyloribiologyallergy and asthma prevention10061 Institute of Molecular Cancer ResearchInterleukin-18tolerogenic dendritic cellsDendritic Cellsgamma-GlutamyltransferaseDendritic cellBiological SciencesAllergensHelicobacter pyloribacterial infections and mycosesmedicine.diseasebiology.organism_classificationAsthmaInterleukin-10respiratory tract diseases3. Good healthMice Inbred C57BLRepressor ProteinsDisease Models AnimalInterleukin 10Basic-Leucine Zipper Transcription FactorsImmunology570 Life sciences; biologyInterleukin 18medicine.symptom
researchProduct

Polyamines Impair Immunity to Helicobacter pylori by Inhibiting L-Arginine Uptake Required for Nitric Oxide Production

2010

International audience; BACKGROUND & AIMS: Helicobacter pylori-induced immune responses fail to eradicate the bacterium. Nitric oxide (NO) can kill H pylori. However, translation of inducible NO synthase (iNOS) and NO generation by H pylori-stimulated macrophages is inhibited by the polyamine spermine derived from ornithine decarboxylase (ODC), and is dependent on availability of the iNOS substrate L-arginine (L-Arg). We determined if spermine inhibits iNOS-mediated immunity by reducing L-Arg uptake into macrophages. METHODS: Levels of the inducible cationic amino acid transporter (CAT) 2, ODC, and iNOS were measured in macrophages and H pylori gastritis tissues. L-Arg uptake, iNOS expressi…

ArginineSpermineNitric Oxide Synthase Type IIArginineNitric OxideOrnithine DecarboxylaseArticleOrnithine decarboxylaseNitric oxideHelicobacter Infections03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineImmune systemGastric mucosamedicinePolyaminesAnimalsHumansCationic Amino Acid Transporter 2Cells Cultured030304 developmental biology0303 health sciencesImmunity CellularHepatologybiologyHelicobacter pyloriReverse Transcriptase Polymerase Chain ReactionMacrophagesGastroenterology[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyHelicobacter pyloribiology.organism_classificationMolecular biologyMice Inbred C57BLDisease Models Animalmedicine.anatomical_structurechemistryGene Expression RegulationGastric Mucosa030220 oncology & carcinogenesisGastritisRNASperminePolyamine
researchProduct

Anti-parietal cell antibodies – diagnostic significance

2015

Anti-parietal cell antibodies (APCA) are an advantageous tool for screening for autoimmune atrophic gastritis (AAG) and pernicious anemia (PA). The target for APCA is the H+/K+ ATP-ase. It has been demonstrated, that APCA target both, the alpha, and beta subunits of the proton pump, although the major antigen is the alpha subunit. Circulating serum APCA can be detected by means of immunofluorescence, enzyme-linked immunosorbent assay – currently the most commonly used method, and radioimmunoprecipitation assay (RIA) – the 4A subunit has been optimized as a molecularspecific antigen probe. RIA is the most accurate method of antibody assessment, characterized by highest sensitivity. APCA can …

Atrophic gastritisAutoimmunityVitiligomedicine.disease_causeImmunofluorescenceAutoimmune DiseasesHelicobacter InfectionsAutoimmunity03 medical and health sciences0302 clinical medicineParietal Cells GastricAntigenmedicineHumansAntigensAutoantibodiespernicious anemiaParietal cellmedicine.diagnostic_testbiologybusiness.industryGeneral Medicinemedicine.diseasemedicine.anatomical_structure030220 oncology & carcinogenesisImmunologyPernicious anemiabiology.protein030211 gastroenterology & hepatologyAutoimmune atrophic gastritisAntibodybusinessAnti-parietal cell antibodiesAdvances in Medical Sciences
researchProduct

Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in I…

2021

Background: Information on the management of Helicobacter (H.) pylori infection by gastroenterologists and gastroenterology fellows are scarce. We aimed to assess practice of gastroenterologists and gastroenterology fellows and their adherence to guidelines for diagnosis and treatment of H. pylori infection in Italy. Materials and Methods: All gastroenterologists and gastroenterology fellows attending the National Congress of Digestive Diseases - FISMAD were invited to fill-in an on-line questionnaire. The questionnaire included questions on the diagnosis and treatment of H. pylori infection. Results: A total of 279 gastroenterologists and 61 gastroenterology fellows participated to the stu…

Background informationHelicobacter pylori infectionmedicine.medical_specialtygenetic structuresdiagnosisgastroenterology fellowGastroenterologyHelicobacter pylori; diagnosis; gastroenterologists; gastroenterology fellows; guidelines; treatment; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy Combination; Humans; Proton Pump Inhibitors; Surveys and Questionnaires; Gastroenterologists; Gastroenterology; Helicobacter Infections; Helicobacter pyloriHelicobacter InfectionsDrug TherapyClarithromycinInternal medicineClarithromycinSurveys and QuestionnairesMedicineHumansguidelinesbiologyHelicobacter pyloritreatmentbusiness.industryGastroenterologistsGastroenterologyAmoxicillinProton Pump InhibitorsGeneral MedicineHelicobacter pyloribiology.organism_classificationeye diseasesAnti-Bacterial AgentsdiagnosiInfectious Diseasesgastroenterology fellowsThird lineCombinationDrug Therapy CombinationgastroenterologistEducational interventionsbusinessguidelineBismuthmedicine.drug
researchProduct

Gene polymorphisms of micrornas in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer.

2013

Background and aims MicroRNAs (miRNAs) are known for their function as translational regulators of tumor suppressor or oncogenes. Single nucleotide polymorphisms (SNPs) in miRNAs related genes have been shown to affect the regulatory capacity of miRNAs and were linked with gastric cancer (GC) and premalignant gastric conditions. The purpose of this study was to evaluate potential associations between miRNA-related gene polymorphisms (miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608) and the presence of GC or high risk atrophic gastritis (HRAG) in European population. Methods Gene polymorphisms were analyzed in 995 subjects (controls: n = 351; GC: n = 363; HRAG: n = 281) of European descen…

Bacterial DiseasesAtrophic gastritislcsh:MedicineGastroenterologyRNA interferenceGastrointestinal CancersBasic Cancer ResearchGenotypeOdds Ratiolcsh:ScienceStomach and DuodenumGeneticsMultidisciplinarybiologyInfectious DiseasesOncologyGastritisMedicineGastritismedicine.symptomResearch ArticleGastritis Atrophicmedicine.medical_specialtySingle-nucleotide polymorphismGastroenterology and HepatologyPolymorphism Single NucleotideWhite PeopleStomach NeoplasmsInternal medicineGastrointestinal TumorsGeneticsmedicineHumansAlleleBiologyHelicobacter pylorilcsh:RCancers and NeoplasmsCancerOdds ratioHelicobacter pylorimedicine.diseasebiology.organism_classificationMicroRNAsGastric CancerLogistic ModelsGenetic Polymorphismlcsh:QGene expressionPopulation GeneticsPLoS ONE
researchProduct